"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
Descriptor ID |
D000369
|
MeSH Number(s) |
M01.060.116.100.080
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 49 | 49 |
1995 | 0 | 52 | 52 |
1996 | 0 | 72 | 72 |
1997 | 0 | 67 | 67 |
1998 | 0 | 61 | 61 |
1999 | 0 | 50 | 50 |
2000 | 0 | 74 | 74 |
2001 | 0 | 72 | 72 |
2002 | 0 | 85 | 85 |
2003 | 0 | 94 | 94 |
2004 | 0 | 106 | 106 |
2005 | 0 | 123 | 123 |
2006 | 0 | 116 | 116 |
2007 | 0 | 140 | 140 |
2008 | 0 | 202 | 202 |
2009 | 0 | 169 | 169 |
2010 | 0 | 196 | 196 |
2011 | 0 | 233 | 233 |
2012 | 0 | 220 | 220 |
2013 | 0 | 242 | 242 |
2014 | 0 | 243 | 243 |
2015 | 0 | 263 | 263 |
2016 | 0 | 262 | 262 |
2017 | 0 | 243 | 243 |
2018 | 0 | 255 | 255 |
2019 | 0 | 266 | 266 |
2020 | 0 | 233 | 233 |
2021 | 0 | 179 | 179 |
2022 | 0 | 31 | 31 |
2023 | 0 | 31 | 31 |
2024 | 0 | 61 | 61 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Optimization of older adults by a geriatric assessment-guided multidisciplinary clinic before CAR T-cell therapy. Blood Adv. 2024 Jul 23; 8(14):3785-3797.
-
Temporal Trends and Racial Disparities in Long-Term Survival After Stroke. Neurology. 2024 Aug 13; 103(3):e209653.
-
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas. Blood Adv. 2024 Jul 09; 8(13):3507-3518.
-
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood Adv. 2024 Jul 09; 8(13):3468-3477.
-
Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer. Cancer Imaging. 2024 Jul 08; 24(1):89.
-
Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations. Sci Rep. 2024 Jul 08; 14(1):15744.
-
Palbociclib in Patients With Soft Tissue Sarcoma With CDK4 Amplifications: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2024 Jul; 8:e2400219.
-
Comparison of the efficacy and safety of SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration. Sci Rep. 2024 06 26; 14(1):14752.
-
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 Jun 18; 14(1):99.
-
Olfactory Impairment and the Risk of Major Adverse Cardiovascular Outcomes in Older Adults. J Am Heart Assoc. 2024 Jun 18; 13(12):e033320.